Applied Capital LLC Eli Lilly & CO Transaction History

Applied Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $179,531 - $247,510	413 New	413 $221,000
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $592 - $675	2 Added 0.23%	863 $279,000
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $3,066 - $3,599	11 Added 1.29%	861 $279,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $191,122 - $237,184	850 New	850 $234,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Applied Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Applied Capital LLC with notifications on news.